Acorah Software Products - Accounts Production 16.6.950 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 13349276 Mrs LE Sutton Mr PM Sutton iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13349276 2024-03-31 13349276 2025-03-31 13349276 2024-04-01 2025-03-31 13349276 frs-core:CurrentFinancialInstruments 2025-03-31 13349276 frs-core:ComputerEquipment 2025-03-31 13349276 frs-core:ComputerEquipment 2024-04-01 2025-03-31 13349276 frs-core:ComputerEquipment 2024-03-31 13349276 frs-core:RevaluationReserve 2024-04-01 2025-03-31 13349276 frs-core:RevaluationReserve 2024-03-31 13349276 frs-core:RevaluationReserve 2025-03-31 13349276 frs-core:ShareCapital 2025-03-31 13349276 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 13349276 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13349276 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 13349276 frs-bus:SmallEntities 2024-04-01 2025-03-31 13349276 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13349276 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13349276 frs-core:DeferredTaxation 2024-04-01 2025-03-31 13349276 frs-core:DeferredTaxation 2024-03-31 13349276 frs-core:DeferredTaxation 2025-03-31 13349276 frs-core:UnlistedNon-exchangeTraded 2025-03-31 13349276 frs-core:UnlistedNon-exchangeTraded 2024-03-31 13349276 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 13349276 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 13349276 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 13349276 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-03-31 13349276 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 13349276 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 13349276 frs-bus:Director1 2024-04-01 2025-03-31 13349276 frs-bus:Director2 2024-04-01 2025-03-31 13349276 frs-countries:EnglandWales 2024-04-01 2025-03-31 13349276 2023-03-31 13349276 2024-03-31 13349276 2023-04-01 2024-03-31 13349276 frs-core:CurrentFinancialInstruments 2024-03-31 13349276 frs-core:RevaluationReserve 2024-03-31 13349276 frs-core:ShareCapital 2024-03-31 13349276 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 13349276
E&O Surgery Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 13349276
2025 2024
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 110 440
Investments 5 465,288 314,484
465,398 314,924
CURRENT ASSETS
Debtors 6 38,799 57,705
Cash at bank and in hand 47,333 228,934
86,132 286,639
Creditors: Amounts Falling Due Within One Year 7 (91,676 ) (77,621 )
NET CURRENT ASSETS (LIABILITIES) (5,544 ) 209,018
TOTAL ASSETS LESS CURRENT LIABILITIES 459,854 523,942
PROVISIONS FOR LIABILITIES
Deferred Taxation 8 (21 ) (84 )
NET ASSETS 459,833 523,858
CAPITAL AND RESERVES
Called up share capital 10 200 200
Revaluation reserve 11 13,506 14,137
Profit and Loss Account 446,127 509,521
SHAREHOLDERS' FUNDS 459,833 523,858
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr PM Sutton
Director
13/06/2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
E&O Surgery Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 13349276 . The registered office is Soughley Cottage, Brown Hills Lane, Sheffield, S10 4PE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25% straight line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences.

3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: 1)
1 1
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 April 2024 1,320
As at 31 March 2025 1,320
Depreciation
As at 1 April 2024 880
Provided during the period 330
As at 31 March 2025 1,210
Net Book Value
As at 31 March 2025 110
As at 1 April 2024 440
Page 3
Page 4
5. Investments
Unlisted
£
Cost
As at 1 April 2024 314,484
Additions 151,435
Revaluations (631 )
As at 31 March 2025 465,288
Provision
As at 1 April 2024 -
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 465,288
As at 1 April 2024 314,484
6. Debtors
2025 2024
£ £
Due within one year
Trade debtors 38,799 28,909
Prepayments and accrued income - 28,746
Other debtors - 50
38,799 57,705
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Corporation tax 89,407 75,383
Accruals and deferred income 2,244 2,222
Directors' loan accounts 25 16
91,676 77,621
8. Deferred Taxation
The provision for deferred tax is made up as follows:
2025 2024
£ £
Other timing differences 21 84
Page 4
Page 5
9. Provisions for Liabilities
Deferred Tax Total
£ £
As at 1 April 2024 84 84
Deferred taxation (63 ) (63 )
Balance at 31 March 2025 21 21
Provision is made for the potential charge to tax that would arise should the company dispose of its fixed assets at the stated net book value to the extent that this is in excess of the tax written down value.
10. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 200 200
11. Reserves
Revaluation Reserve
£
As at 1 April 2024 14,137
Transfer to profit and loss (631 )
As at 31 March 2025 13,506
Page 5